Literature DB >> 9363260

Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.

H C Liu1, E Pyrgiotis, O Davis, Z Rosenwaks.   

Abstract

Luteal-phase estrogen and progesterone concentrations were measured every other day and used to monitor the corpus luteum activity. The patterns of estrogen and progesterone concentrations were compared relative to the day of endogenous human chorionic gonadotropin (hCG) detection (defined as the day of implantation). The relationship between estrogen and progesterone and hCG concentrations was studied in 71 viable pregnancies, 12 clinical abortions, five preclinical abortions and 84 non-pregnant cycles after IVF/ET. Although all patients received luteal-phase progesterone support (25-50 mg/ml), low late luteal-phase progesterone concentrations of < 30 ng/ml from day + 11 to day + 15 were found in 64 patients (17% of viable pregnancies, 33.3% of clinical abortions, 60% of preclinical abortions and 53.6% of non-pregnant cycles) day + 1 was the day of retrieval). Implantation always occurred before or on day + 13 and 86% of pregnant cycles implanted on day + 8 to day + 11. Viable pregnancies had significantly higher mean progesterone concentrations on day + 3 to day + 7 (pre-implantation) and on day + 9 to day + 15 (postimplantation) than those of non-pregnant cycles or abortions. On the day of implantation, the mean +/- standard of deviation of estrogen (pg/ml) and progesterone (ng/ml) levels for viable pregnancies, clinical abortion and preclinical abortions were 314 +/- 210, 40.5 +/- 25; 226.7 +/- 246, 48.7 +/- 31; and 39.6 +/- 24.5, 28.6 +/- 24.5, respectively. On the same day, 73.2% of viable pregnancies, 41.7% of clinical abortions, and 20% preclinical abortions had a progesterone concentration > 30 ng/ml; 73.2% of viable pregnancies, 41.7% of clinical abortions and 20% of preclinical abortions had an estrogen concentration > 100 pg/ml. Although not precluding implantation completely, late luteal-phase hormonal deficiencies may impair endometrial growth and might ultimately lead to failure or abnormal implantation. A viable pregnancy requires not only a functional corpus luteum in the early luteal phase to develop a receptive endometrium, but also a responsive corpus luteum in the late luteal phase to support pregnancy. The time of implantation is critical. Implantation that occurs before the demise of the corpus luteum will facilitate a normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9363260

Source DB:  PubMed          Journal:  Early Pregnancy        ISSN: 1354-4195


  6 in total

1.  Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone alpha subunit gene by epidermal growth factor and forskolin.

Authors:  M S Roberson; M Ban; T Zhang; J M Mulvaney
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience.

Authors:  C Yding Andersen; R Fischer; V Giorgione; Thomas W Kelsey
Journal:  J Assist Reprod Genet       Date:  2016-07-22       Impact factor: 3.412

3.  Homeobox gene Distal-less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction.

Authors:  Amy Chui; Charmaine Tay; Melanie Cocquebert; Penelope Sheehan; Niroshani A Pathirage; Susan Donath; Thierry Fournier; Josette Badet; Daniele Evain-Brion; Shaun P Brennecke; Bill Kalionis; Padma Murthi
Journal:  J Mol Med (Berl)       Date:  2011-11-24       Impact factor: 4.599

4.  Urinary hCG patterns during the week following implantation.

Authors:  P A Nepomnaschy; C R Weinberg; A J Wilcox; D D Baird
Journal:  Hum Reprod       Date:  2007-12-14       Impact factor: 6.918

5.  Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturation.

Authors:  Barbara Lawrenz; Nicolas Garrido; Suzan Samir; Francisco Ruiz; Laura Melado; Human M Fatemi
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

6.  Distinct spatiotemporal expression of serine proteases Prss23 and Prss35 in periimplantation mouse uterus and dispensable function of Prss35 in fertility.

Authors:  Honglu Diao; Shuo Xiao; Rong Li; Fei Zhao; Xiaoqin Ye
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.